Speaker illustration

Doctor Hirotoshi Watanabe

Hirakata Kohsai Hospital, Hirakata (Japan)

Member of:

European Society of Cardiology

2005: Graduated from Kyoto University, Medical Faculty Passed the Examination of National Board (M.D) 2005-2007: Junior Resident, National Hospital Organization Kyoto Medical Center, Kyoto 2007-2008: Senior Resident, Kokura Memorial Hospital, Devision of Cardiology 2009-2013: Medical Staff, Kokura Memorial Hospital, Devision of Cardiology 2013-2017: Medical Staff, Kyoto University Graduate School of Medicine, Kyoto University Hospital 2016: Received Ph.D. in Kyoto University, Graduate School of Medicine (Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2) 2017-Present: Research Associates in Department of Cardiovascular Medicine, Kyoto University Hospital

STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome

Event: ESC Congress 2021 - The Digital Experience

Topic: Adjunctive Pharmacotherapy

Session: Hot Line - STOPDAPT-2 ACS


Post-discharge myocardial infarction after percutaneous coronary intervention: incidence, risk factors, size distribution and its prognostic significance

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: PCI - Long-term outcome


This platform is supported by

logo Novo Nordisk